Experimental application of target-specific immunoconjugates containing daunomycin as the cytocidal component.
作者信息
Diener E, Xie S S, Yu L Z, Longenecker B M, Sinha A A
机构信息
University of Alberta, Edmonton, Canada.
出版信息
Targeted Diagn Ther. 1988;1:1-23.
PMID:2979054
Abstract
摘要
相似文献
1
2
Application of target-specific drug immunoconjugates to experimental bone marrow replacement therapy in mice.
Cancer Res. 1990 Mar 1;50(5):1538-43.
3
The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
Cancer Res. 1993 Dec 1;53(23):5740-4.
4
Comparison of the cytotoxic activity of the immunotoxins with different internalization rate.不同内化速率的免疫毒素细胞毒性活性比较。
Biochem Mol Biol Int. 1993 Dec;31(6):1059-69.
5
The use of anthracycline-antibody complexes for specific antitumor activity.使用蒽环类抗生素 - 抗体复合物实现特异性抗肿瘤活性。
Targeted Diagn Ther. 1988;1:25-53.
6
Specific immunosuppression by immunotoxins containing daunomycin.含柔红霉素免疫毒素的特异性免疫抑制作用。
Science. 1986 Jan 10;231(4734):148-50. doi: 10.1126/science.3484557.
7
Coupling daunorubicin to monoclonal antialphafoetoprotein with a new activated derivative.用一种新型活化衍生物将柔红霉素与单克隆抗甲胎蛋白偶联。
Int J Immunopharmacol. 1990;12(5):503-7. doi: 10.1016/0192-0561(90)90113-2.
8
Superiority of an acid-labile daunorubicin-monoclonal antibody immunoconjugate compared to free drug.酸不稳定柔红霉素-单克隆抗体免疫缀合物相对于游离药物的优越性。
Cancer Res. 1988 Nov 1;48(21):6097-102.
9
Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.同基因骨髓移植后小鼠体内CD40刺激的免疫和造血效应
J Clin Invest. 1997 Feb 1;99(3):484-91. doi: 10.1172/JCI119183.
引用本文的文献
1
Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomas.使用一种针对哺乳动物鳞状癌增殖区室的新型单克隆抗体实现有效的药物-抗体靶向。
Cancer Immunol Immunother. 1990;32(2):105-9. doi: 10.1007/BF01754206.
Zotero 插件